- Brief Report
- Open Access
Results of silicone oil removal in post-cytomegalovirus retinitis-related retinal detachment
- Vivek Pravin Dave1Email author,
- Annie Mathai1 and
- Rajeev R. Pappuru1
https://doi.org/10.1007/s12348-012-0060-3
© The Author(s) 2012
- Received: 13 December 2011
- Accepted: 19 January 2012
- Published: 15 February 2012
Abstract
Purpose
The purpose of this study is to evaluate the results of silicone oil removal (SOR) in post-cytomegalovirus (CMV) retinitis-related retinal detachment in Indian eyes.
Methods
A retrospective review of CMV retinitis-related retinal detachment following SOR was conducted.
Results
Out of 60 eyes (55 patients) that had vitrectomy with silicone oil tamponade between 1995 and 2010, 11 eyes underwent SOR. There were two females and eight males, and the mean age was 41.27 ± 9.8 years. The duration between primary detachment surgery and SOR was 8.82 ± 2.56 months. The mean duration of HIV positivity was 33 ± 28.65 months (nearly 3 years). The average CD4 cell count at the time of SOR was 365 ± 85 cells/mm3. The mean best corrected pre-SOR visual acuity in logMAR was 1 ± 0.85, and the post-SOR acuity was 1.13 ± 0.67 (p = 0.69). The mean follow-up post-SOR was 7.54 ± 7.76 months. Out of the 11 eyes that underwent SOR, in 9 eyes, the retina was attached at the last follow-up. The anatomical success rate following SOR was 81.82% (9/11; CI, 59.03–100%).
Conclusion
The results of this study suggest a relatively low redetachment rate following SOR in CMV retinitis-related retinal detachment.
Keywords
- CMV retinitis
- Retinal detachment
- Silicone oil removal
- CD4 cell counts
Introduction
Cytomegalovirus (CMV) retinitis is a well-recognized cause of retinal detachment in immunocompromised patients with acquired immunodeficiency syndrome (AIDS). Retinal detachments in these cases occur due to necrotic breaks at the junction of healed retinitis and normal retina. As the breaks are usually multiple, irregular, in thin retina, and difficult to visualize, primary vitrectomy with long-term endotamponade with silicone oil is the preferred modality of management in these detachments [1–4]. Though good efficacy of gas tamponade with an encircling scleral buckle has been shown in a previous study with almost 83% success rate, the total cohort was very small (six eyes). Primary vitrectomy still remains the treatment option of choice [5, 6]. Due to the inherent drawbacks of silicone oil in situ like hyperopic shift and cataractogenesis, silicone oil removal (SOR) is desirous in these cases at an optimal time [7, 8]. Though safety of silicone oil removal in post-CMV retinitis-related retinal detachment surgeries has been described before, the literature on this subset of cases is scarce [9, 10]. The purpose of this article is to assess the outcome of silicone oil removal in cases of CMV retinitis-related retinal detachment that were repaired by vitrectomy with silicone oil tamponade.
Materials and methods
This study was a retrospective noncomparative interventional case series. The records of patients with CMV retinitis-related retinal detachment that underwent pars plana vitrectomy with silicone oil injection at a tertiary eye care institute in south India between January 1995 and October 2010 were retrospectively reviewed. The criterion used to plan oil removal was a minimum interval of 6 months following the primary vitrectomy and a completely attached retina without any unlasered retinal breaks. In all cases, silicone oil removal was planned once emulsification was noted to have begun. All patients gave a written informed consent. All surgeries were performed by or under direct supervision of two senior retinal surgeons (A.M. and R.R.P). The procedure consisted of a two-port setup, and SOR was done using a 19-G cannula on a syringe under negative suction. After SOR, the retina was examined on table with an endoilluminator to rule out any recurrent detachment and to look for adequacy of endolaser. Additional laser was applied on table as deemed necessary by making an additional sclerotomy port. Strict aseptic precautions were adhered to during surgery with adequate protective gear for the surgical and assisting team and disposal of all materials used during the surgery to prevent any risk of HIV transmission.
The data collected from the patient’s records included the patient’s age, gender, preoperative best-corrected visual acuity, postoperative best-corrected visual acuity, the type of anti-CMV treatment used, use of encirclage at the time of primary detachment surgery, time interval between the initial detachment surgery and SOR, viscosity of the silicone oil used, and whether or not SOR was combined with cataract surgery. The outcome measure studied was the number of eyes with attached retina following silicone oil removal at the last follow-up. The statistical analysis was done using the Statistical Package for Social Sciences version 16. The preoperative and postoperative visual acuity were compared using the paired t test. A p value of <0.05 was assigned as significant. The confidence intervals around the percentages were calculated by the mid-P exact test.
Results
During the study period, there were 60 eyes of 55 patients who underwent primary vitrectomy with silicone oil tamponade for repair of CMV retinitis-related retinal detachment. Of these, 11 eyes of ten patients underwent SOR. Of the remaining eyes, 37 eyes were lost to follow-up before 6 months, while the remaining 12 had recurrent detachment. There were two females and eight males, and the mean age was 41.27 ± 9.8 years. The duration between primary detachment surgery and SOR was 8.82 ± 2.56 months. The mean duration of HIV positivity was 33 ± 28.65 months (nearly 3 years). The average CD4 cell count at the time of SOR was 365 ± 85 cells/mm3. The mean best-corrected pre-SOR visual acuity in logMAR was 1 ± 0.85, and the post-SOR acuity was 1.13 ± 0.67 (p = 0.69). The mean preoperative intraocular pressure (IOP) noted was 16.9 ± 2.88 mm Hg, and the postoperative IOP was 13.63 ± 2.34 mm Hg. One eye had an encirclage band passed before vitrectomy. Three eyes had active CMV retinitis when detachment developed, while the rest had healed CMV lesions. Those with active disease were put on oral Valgancyclovir 900 mg twice a day. The CD4 counts were recorded to monitor the immune status. Six out of the ten patients were on highly active antiretroviral therapy (HAART) at presentation. The rest were examined by the internist and started on HAART subsequently. Four eyes had 5,000 cs silicone oil used, while seven eyes had 1,000 cs oil.
Causes of poor vision post-silicone oil removal
Patient number | Redetachment | Optic atrophy | Epiretinal membrane | Corneal scar | Vitritis | Macular scarring |
|---|---|---|---|---|---|---|
1 | − | + | − | − | − | + |
2 | + | + | − | − | − | − |
3 | + | − | − | + | − | − |
4 | − | − | − | − | − | − |
5 | − | − | − | − | − | − |
6 | − | − | + | − | − | − |
7 | − | − | − | − | + | + |
8 | − | + | + | − | + | + |
9 | − | − | + | + | − | + |
10 | − | + | − | − | − | − |
11 | − | + | − | − | − | − |
Discussion
Silicone oil is the preferred tamponade following vitrectomy for retinal detachment surgeries associated with CMV retinitis. A wide range of retinal attachment rate varying from 8–95% has been reported in the literature for these cases with silicone oil tamponade [1, 9] With the advent of the HAART therapy for HIV patients, the life expectancy has increased over a period of time. Thus, an increased longevity necessitates SOR in many patients who have undergone primary vitreous surgery with silicone oil tamponade. As there is paucity of literature on the outcomes of such eyes following SOR, our study aimed to document the outcomes of these eyes. A similar study conducted by Morrison et al. [10] reported a 53% rate of redetachment after silicone oil removal at a median period of 4 months post-SOR. Nine eyes in their series had C3F8, SF6, or air injection at the end of surgery. They observed that simultaneous cataract surgery at the time of SOR and lower CD4 cell counts were associated with a greater risk of redetachment. Our study showed a redetachment rate of 18.2% (2/11; 95% CI, 0–41%). The mean CD4 cell count in their study was 173 cells/mm3, while that in our study was 365 cells/mm3. Also, none of our patients had cataract surgery combined with the SOR at the same sitting. The high CD4 cell count indicates a greater immune competence and possibly could be hypothesized to have contributed to better surgical outcome [11].
Our study has a few inherent limitations and observations. Being a retrospective study, the results need to be interpreted with caution. As the overall sample size is small (11 eyes) and the number of unfavorable events being still smaller (two redetachments), to derive any statistical inference from this study would be erroneous. The overall follow-up is short, both after the primary surgery and after silicone oil removal. This is possibly due to the majority of patients belonging to the lower socioeconomic strata as well as the high mortality associated with AIDS. Among the eyes that did not undergo SOR, 12 eyes had recurrent detachment. A high rate of loss of follow-up (62%) is a major limiting factor of the present study.
In summary, among the eyes that did not undergo SOR, 12 eyes had recurrent detachment. Overall, 14 out of 23 eyes (61%; CI, 40–79%) developed recurrent retinal detachment on follow-up. Our series also showed a retinal attachment rate of 82% following silicone oil removal at a mean follow-up of 7.5 months in eyes that underwent vitrectomy for CMV retinitis-related retinal detachment. This is an improvement on the rates that have been reported in the literature and could be attributed to the higher CD4 counts. Thus, though the overall redetachment rate post-vitrectomy with silicone oil is poor, in cases with attached retina over 6 months, there is a high attachment rate seen post-SOR. A larger prospective series with a longer follow-up is desirous to further validate these results.
Authors’ Affiliations
References
- Davis JL, Serfass MS, Lai MY, Trask DK, Azen SP (1995) Silicone oil in repair of retinal detachments caused by necrotizing retinitis in HIV infection. Arch Ophthalmol 113:1401–1409PubMedView ArticleGoogle Scholar
- Sandy CJ, Bloom PA, Graham EM, Ferris JD, Shah SM, Schulenburg WE et al (1995) Retinal detachment in AIDS-related cytomegalovirus retinitis. Eye 9(Pt 3):277–281PubMedView ArticleGoogle Scholar
- Freeman WR, Quiceno JI, Crapotta JA, Listhaus A, Munguia D, Flores-Aguilar M (1992) Surgical repair of rhegmatogenous retinal detachment in immunosuppressed patients with cytomegalovirus retinitis. Ophthalmology 99:466–474PubMedView ArticleGoogle Scholar
- Jabs DA, Enger C, Haller J, de Bustros S (1991) Retinal detachments in patients with cytomegalovirus retinitis. Arch Ophthalmol 109:794–799PubMedView ArticleGoogle Scholar
- Canzano JC, Morse LS, Wendel RT (1999) Surgical repair of cytomegalovirus-related retinal detachment without silicone oil in patients with AIDS. Retina 19:274–280PubMedView ArticleGoogle Scholar
- Charteris DG (1997) Surgical management of HIV related retinal detachment. Br J Ophthalmol 81:177–179PubMedPubMed CentralView ArticleGoogle Scholar
- Irvine AR (1991) Treatment of retinal detachment due to cytomegalovirus retinitis in patients with AIDS. Trans Am Ophthalmol Soc 89:349–363, discussion 363–367PubMedPubMed CentralGoogle Scholar
- Federman JL, Schubert HD (1988) Complications associated with the use of silicone oil in 150 eyes after retina-vitreous surgery. Ophthalmology 95:870–876PubMedView ArticleGoogle Scholar
- Azen SP, Scott IU, Flynn HW et al (1998) Silicone oil in the repair of complex retinal detachments. Ophthalmology 105:1587–1597PubMedView ArticleGoogle Scholar
- Morrison VL, Labree LD, Azen SP, Goldberg DE, Freeman WR (2005) Results of silicone oil removal in patients with cytomegalovirus retinitis related retinal detachments. Am J Ophthalmol 140:786–793PubMedView ArticleGoogle Scholar
- Kempen JH, Jabs DA, Dunn JP, West SK, Tonascia J (2001) Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome. Arch Ophthalmol 119:33–40PubMedGoogle Scholar
Copyright
This article is published under license to BioMed Central Ltd. Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution and reproduction in any medium, provided the original author(s) and the source are credited.
